A representative from the drug company Repligen appeared before the Select Board on Aug. 3 to discuss the company’s interest in taking over a vacant building on South Street and working on a Tax Increment Finance (TIF) agreement to provide incentive.

Steve Curran, the company’s vice president, global operations, explained that Repligen, which was founded in 1981, switched a few years ago to become a “solution company.”

“We provide tools and solutions to help drug companies get to market faster,” Curran said.

The company’s headquarters are in Waltham, and it already expanded to Marlborough.

Repligen is looking at 99 South St., which has been vacant for nine years. Its intention is to add 200 jobs and invest $15 million of private investment into the building.

The Select Board unanimously approved the town manager to negotiate a TIF. An agreement ultimately would require approval at Town Meeting.

Resident starts personal training business

Hopkinton’s Kate Stone, who has worked as a certified medical exercise specialist for over 20 years in Boston, recently started her own business, Myologie, which offers individual in-home training as well as virtual sessions.

According to the company’s website (myologie.net), Stone’s mission is “to improve and enhance your life by teaching you about your body and showing you how to do the activities you love doing — without pain. My expertise is getting you to a level of activity and fitness that you have been told would not be possible for you — in a fun, caring and compassionate way!”

LakePharma acquired by Curia

The biologics company LakePharma, which has offices in Hopkinton, announced last month that it had finalized an agreement to be acquired by Curia, a contract, research, development and manufacturing organization based in Albany. LakePharma focuses on drug discovery, clinical research, development and manufacturing.